symbol: MTLF
Cycle B.N.:
0
Change:
%
At:
00:00
True to:
01/01/1970

Company profile

Matricelf is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions. The company was established in 2019 by Professor Tal Dvir of the Laboratory for Tissue Engineering and Regenerative Medicine from Tel Aviv University.

Download Materials

Investor Deck 2023 – En

Investor Deck 2023 – Heb

דוח תקופתי לשנת מונגש 2022

2022 H1 Financial Report

Investor Presentation – Heb

Investor Presentation – En

Matricelf 2021 financial report

תשקיף